Sarda Proteins Approves Rights Issue Up to ₹100 Crore

Sarda Proteins Limited's Board of Directors has approved the issuance of equity shares on a rights basis, aiming to raise up to ₹100 crore. The company will file a Draft Letter of Offer (DLOF) with SEBI and stock exchanges. A Rights Issue Committee has been formed to oversee the process. The board also noted the resignation of non-executive director Mr. Gunvantray Jayantilal Zaladi due to personal reasons. The record date for the rights issue will be announced separately.